Bath & Body Works, Inc. $BBWI Shares Purchased by Jupiter Asset Management Ltd.

Jupiter Asset Management Ltd. raised its stake in Bath & Body Works, Inc. (NYSE:BBWIFree Report) by 553.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,714,499 shares of the company’s stock after purchasing an additional 3,145,797 shares during the period. Bath & Body Works accounts for about 0.8% of Jupiter Asset Management Ltd.’s holdings, making the stock its 23rd biggest position. Jupiter Asset Management Ltd. owned 1.80% of Bath & Body Works worth $95,685,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also modified their holdings of the company. First Horizon Corp acquired a new stake in Bath & Body Works during the 3rd quarter worth $29,000. Geneos Wealth Management Inc. raised its holdings in shares of Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after buying an additional 801 shares during the last quarter. Carolina Wealth Advisors LLC acquired a new stake in shares of Bath & Body Works during the third quarter worth about $54,000. Parkside Financial Bank & Trust grew its holdings in shares of Bath & Body Works by 24.6% during the second quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock worth $55,000 after buying an additional 364 shares during the last quarter. Finally, Westfuller Advisors LLC purchased a new position in shares of Bath & Body Works during the third quarter worth about $56,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Stock Up 1.0%

Shares of NYSE BBWI opened at $24.15 on Friday. The stock has a market capitalization of $4.94 billion, a price-to-earnings ratio of 7.43, a price-to-earnings-growth ratio of 1.05 and a beta of 1.54. Bath & Body Works, Inc. has a 52 week low of $14.27 and a 52 week high of $41.87. The firm has a 50-day moving average price of $21.72 and a 200 day moving average price of $23.99.

Bath & Body Works (NYSE:BBWIGet Free Report) last issued its earnings results on Thursday, November 20th. The company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.40 by ($0.05). Bath & Body Works had a negative return on equity of 47.35% and a net margin of 9.50%.The company had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the previous year, the company posted $0.49 earnings per share. The company’s quarterly revenue was down 1.0% compared to the same quarter last year. Equities research analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 6th. Investors of record on Friday, February 20th will be paid a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 3.3%. The ex-dividend date of this dividend is Friday, February 20th. Bath & Body Works’s dividend payout ratio (DPR) is presently 24.62%.

Analyst Ratings Changes

Several research analysts have weighed in on the company. Weiss Ratings reiterated a “hold (c-)” rating on shares of Bath & Body Works in a research note on Wednesday, January 21st. JPMorgan Chase & Co. lowered their target price on shares of Bath & Body Works from $26.00 to $15.00 and set a “neutral” rating on the stock in a report on Thursday, November 20th. Robert W. Baird set a $20.00 price target on shares of Bath & Body Works in a report on Wednesday, December 17th. Jefferies Financial Group initiated coverage on Bath & Body Works in a report on Wednesday, January 14th. They issued a “hold” rating and a $24.00 price objective on the stock. Finally, Telsey Advisory Group cut Bath & Body Works from an “outperform” rating to a “market perform” rating and dropped their target price for the stock from $38.00 to $17.00 in a research report on Friday, November 21st. Four equities research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $23.21.

Read Our Latest Research Report on BBWI

Bath & Body Works News Roundup

Here are the key news stories impacting Bath & Body Works this week:

Bath & Body Works Company Profile

(Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Read More

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.